AMPK activation protects astrocytes from hypoxia‑induced cell death

Abstract

Adenosine monophosphate (AMP)-activated protein kinase (AMPK) is a major cellular energy sensor that is activated by an increase in the AMP/adenosine triphosphate (ATP) ratio. This causes the initiation of adaptive cellular programs, leading to the inhibition of anabolic pathways and increasing ATP synthesis. AMPK indirectly inhibits mammalian target of rapamycin (mTOR) complex 1 (mTORc1), a serine/threonine kinase and central regulator of cell growth and metabolism, which integrates various growth inhibitory signals, such as the depletion of glucose, amino acids, ATP and oxygen. While neuroprotective approaches by definition focus on neurons, that are more sensitive under cell stress conditions, astrocytes play an important role in the cerebral energy homeostasis during ischemia. Therefore, the protection of astrocytic cells or other glial cells may contribute to the preservation of neuronal integrity and function. In the present study, it was thus hypothesized that a preventive induction of energy deprivation-activated signaling pathways via AMPK may protect astrocytes from hypoxia and glucose deprivation. Hypoxia-induced cell death was measured in a paradigm of hypoxia and partial glucose deprivation in vitro in the immortalized human astrocytic cell line SVG. Both the glycolysis inhibitor 2-deoxy-d-glucose (2dG) and the AMPK activator A-769662 induced the phosphorylation of AMPK, resulting in mTORc1 inhibition, as evidenced by a decrease in the phosphorylation of the target ribosomal protein S6 (RPS6). Treatment with both 2dG and A-769662 also decreased glucose consumption and lactate production. Furthermore, A-769662, but not 2dG induced an increase in oxygen consumption, possibly indicating a more efficient glucose utilization through oxidative phosphorylation. Hypoxia-induced cell death was profoundly reduced by treatment with 2dG or A-769662. On the whole, the findings of the present study demonstrate, that AMPK activation via 2dG or A-769662 protects astrocytes under hypoxic and glucose-depleted conditions.

TIMP3 attenuates cerebral ischemia/reperfusion‑induced apoptosis and oxidative stress in neurocytes by regulating the AKT pathway

“…However, the specific binding molecules and their sites of binding to TIMP3 to modify the phosphorylation of AKT in I/R injury were unknown, which will be investigated further in the future. It has been previously demonstrated that the AKT pathway is activated in hypoxia-induced neuronal injury, which is contrary to the findings of the present study (28). These inconsistent results may be caused by the different models applied.…”

AMP-kinase mediates adaptation of glioblastoma cells to conditions of the tumour microenvironment

“…Therefore, tumour cells are more susceptible to the treatment with glycolysis inhibitors like 2-DG 50 . In consequence of glycolysis inhibition, ATP is depleted and AMPK is activated 8,51 . Our results demonstrate that AMPK DKO cells show an impaired adaptation to energy starvation conditions and thus it seems plausible that these cells are more sensitive to glycolysis inhibition than wildtype cells.…”

Electrical Stimulation Increases the Secretion of Cardioprotective Extracellular Vesicles from Cardiac Mesenchymal Stem Cells

“…We used an in vitro hypoxia model to simulate cardiac ischemia. Mouse cardiomyocyte cells (HL-1) cultured in BD GasPak Pouches (BD Biosciences, Cockeysville, MD, USA) were subjected to hypoxia (0.1% oxygen) for 16 h [ 25 ]. HL-1 cell apoptosis was detected using the DeadEnd™ Colorimetric TUNEL System.…”